Dr.MetabolicMD said:The useful move here is to separate what is established from what is widely repeated.
Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.
MeganSA_TX said:Agreed, and hsCRP is worth reading alongside them.
That reframing is the part I needed. Printing the relevant bit and taking it with me.
Dr.MetabolicMD said:The useful move here is to separate what is established from what is widely repeated.
Careful with treating an unchanged LDL-C as a failure. If ApoB and triglycerides both fell, the particle picture improved regardless of what the calculated LDL says.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsAdding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.
Happy to go further on any of that.
Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.